Artha Sootra - Company Dashboard

Governance Classic Home

Krebs Biochemicals & Industries LtdPharmaceuticalsINE268B01013

Valuation

Market Cap₹123.11 Cr

TTM PE-9.22x

Forward PE-9.03x

PEG1.72

Book Value—

P/B—

TTM EPS₹-6.19

Fwd EPS₹-6.32

TTM Revenue₹26.85 Cr

TTM PAT₹-13.35 Cr

TTM EBITDA₹-1.67 Cr

TTM EBIT₹-8.08 Cr

Last Qtr PAT₹-2.48 Cr

Last Qtr EBITDA₹-1.93 Cr

Last Qtr EBIT₹-3.54 Cr

Profitability

ROE—

ROCE-10.00%

TTM NPM-49.72%

TTM EBITDA %-6.22%

Curr OPM-92.62%

Last OPM-34.73%

Curr NPM—

Last NPM—

Curr EPS₹-2.50

Last EPS₹-1.15

Balance sheet

Equity₹21.56 Cr

Reserve₹-192.20 Cr

Total Debt₹226.99 Cr

D/E—

Interest %-35.19%

Curr Interest₹1.90 Cr

Price / range

Close₹57.10

vs 52W High-25.57%

vs 52W Low+48.23%

MA50—

MA200—

Returns

1D+2.11%

1W-3.47%

1M-16.09%

3M+5.18%

6M-3.87%

1Y-19.34%

2Y-31.82%

3Y-27.94%

5Y-67.06%

Diwali-17.05%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	130.40	3.70%
DIVISLAB	10037.50	₹2.66L Cr	90.60	17.55%
TORNTPHARM	4738.50	₹1.60L Cr	83.32	11.07%
LAURUSLABS	2323.80	₹1.25L Cr	120.09	17.24%
ZYDUSLIFE	1188.10	₹1.20L Cr	38.84	11.33%
DRREDDY	1374.00	₹1.15L Cr	413.86	2.50%
CIPLA	1402.00	₹1.13L Cr	42.73	7.49%
MANKIND	2537.90	₹1.05L Cr	45.48	13.10%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	5.79+38.8%	6.98	6.81	7.27	4.17	23.73
Other Income	0.04	0.16	2	0	0.01	2.03
Total Income	5.83+39.8%	7.14	8.81	7.28	4.17	25.76
Interest	1.90	1.88	1.91	1.79	1.73	7.09
Expenditure	-11.23-8.8%	-9.62	-11.15	-10.41	-10.32	-42.69
PBDT	0	0	0	0	0	0
EBITDA	-1.93+31.1%	0.83	-0.86	0.29	-2.80	-5.45
Depreciation	-1.61	-1.59	-1.57	-1.64	-1.62	-6.42
EBIT	-3.54+19.9%	-0.76	-2.43	-1.35	-4.42	-11.87
PBT	-5.40+12.1%	-2.48	-2.34	-3.13	-6.14	-16.93
Tax	0	0	0	0	0	0
Equity	21.56	21.56	21.56	0	0	21.56
OPM	-92.62	-34.73	-26.56	-42.99	-147.42	-65.74
Net Profit	-5.40+12.1%	-2.48	-2.34	-3.13	-6.14	-16.93
NPM	-92.62	-34.73	-26.56	-42.99	-147.42	-65.74
EPS	-2.50+12.3%	-1.15	-1.09	-1.45	-2.85	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	23.73-45.2%	43.31-14.1%	50.42-3.3%	52.13-1.5%	52.94-1.4%	53.70
Other Income	2.03	0.71	0.45	0.62	7.92	0.62
Total Income	25.76-41.5%	44.02-13.5%	50.87-3.6%	52.76-13.3%	60.86+12.0%	54.32
Expenditure	-42.69+39.8%	-70.94-0.5%	-70.60+8.8%	-77.45+26.5%	-105.39-27.5%	-82.68
Interest	-7.09	-5.91	-4.69	-2.97	-5.39	-6.28
PBDT	0	0	0	0	0	0
EBITDA	-5.45+63.7%	-15.03-72.4%	-8.72+44.8%	-15.79+61.3%	-40.76-131.9%	-17.58
Depreciation	-6.42	-6.69	-6.77	-6.56	-6.30	-5.12
EBIT	-11.87+45.3%	-21.72-40.2%	-15.49+30.7%	-22.35+52.5%	-47.06-107.3%	-22.70
PBT	-16.93+37.1%	-26.92-36.4%	-19.73+20.1%	-24.69+44.6%	-44.53-57.0%	-28.36
Tax	0	-0.02	0	0	0	0
Equity	21.56	21.56	0	0	0	0
OPM (%)	-65.74	-61.16	-39.00	-47.00	-73.00	-52.00
Net Profit	-16.93+37.2%	-26.94-36.5%	-19.73+20.1%	-24.69+44.6%	-44.53-57.0%	-28.36
NPM (%)	-65.74	-61.20	-39.00	-47.00	-73.00	-52.00
EPS (Rs)	0	0+100.0%	-9.16+18.9%	-11.30+45.7%	-20.81-43.2%	-14.53
CEPS	0	0	-9.16	-11.30	-20.81	-14.53

Metric	FY25-26
Revenue	23.73
Other Income	2.03
Total Income	25.76
Interest	7.09
Expenditure	-42.69
PBDT	0
EBITDA	-5.45
Depreciation	-6.42
EBIT	-11.87
PBT	-16.93
Tax	0
Equity	21.56
OPM	-65.74
Net Profit	-16.93
NPM	-65.74
EPS	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	23.73-45.2%	43.31
Other Income	2.03	0.71
Total Income	25.76-41.5%	44.02
Expenditure	-42.69+39.8%	-70.94
Interest	-7.09	-5.91
PBDT	0	0
EBITDA	-5.45+63.7%	-15.03
Depreciation	-6.42	-6.69
EBIT	-11.87+45.3%	-21.72
PBT	-16.93+37.1%	-26.92
Tax	0	-0.02
Equity	21.56	21.56
OPM (%)	-65.74	-61.16
Net Profit	-16.93+37.2%	-26.94
NPM (%)	-65.74	-61.20
EPS (Rs)	0	0
CEPS	0	0

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split